Intuitive Surgical (ISRG) Shares Sell Off As Outlook Commentary is Meager

Intuitive Surgical, Inc. (Nasdaq: ISRG) topped Q2 estimates by $0.19, but the shares are getting hammered in after-hours, down $32.31 (-5.94%) to $511.90. Investors are selling off as the company expects a drop in systems sales in the second half of the year. ISRG expects challenging conditions to persist, with continued uncertainty in Europe.

Commenting on Q2 earnings, Dr. Gary Guthart, President and CEO of Intuitive Surgical, said, "Our solid second quarter revenue and earnings performance is the result of robust US gynecologic and general surgery procedure growth offset by pressure in Europe and US prostatectomy."

The growth in second quarter 2012 systems revenue was driven by sales of 150 da Vinci Surgical Systems compared with 129 system sales during the same period last year.

In the past year, shares have climbed from ~$350 to $590, before recently giving some back. The stock finished the day at $544.21, but again, now trading down about $30.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• General Motors (GM) PT Raised to $45 at Piper Sandler
• Root, Inc. (ROOT) PT Raised to $70 at Keefe, Bruyette & Woods